To further investigate Lgr5 expression in CRC tumors at various stages, we in the present study aimed to analyze and compare the heterogeneous expression of Lgr5 at the tumour center, invasive front, and TB of CRC staged as pTNM I–IV and explore its relationship with clinicopathological and prognostic characteristics of CRC. Here, LGR5 is linked to neoplasm.